STOCK TITAN

Viatris (VTRS) awards 59,323 RSUs to Chief Legal Officer

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Maletta Matthew Joseph reported acquisition or exercise transactions in this Form 4 filing.

Viatris Inc reported that Chief Legal Officer Matthew Joseph Maletta received a grant of 59,323 restricted stock units on March 6, 2026. Each RSU represents one share of Viatris common stock. The award vests in three annual tranches: 19,775 RSUs on March 6, 2027 and 19,774 RSUs on each of March 6, 2028 and March 6, 2029. Following this compensation-related grant, Maletta holds 59,323 RSUs directly.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maletta Matthew Joseph

(Last) (First) (Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PA 15317

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0 03/06/2026 A 59,323 (1) (1) Common Stock 59,323 $0 59,323 D
Explanation of Responses:
1. Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. 19,775 of the RSUs granted on March 6, 2026 will vest on March 6, 2027 and 19,774 will vest on each of March 6, 2028 and March 6, 2029.
/s/ Kevin Macikowski, by power of attorney 03/10/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Viatris (VTRS) report for Matthew Joseph Maletta?

Viatris reported a grant of 59,323 restricted stock units to Chief Legal Officer Matthew Joseph Maletta. This is a compensation-related award, not an open-market purchase or sale of shares, and reflects equity-based incentives tied to future vesting dates.

How many restricted stock units did the Viatris (VTRS) Chief Legal Officer receive?

The Chief Legal Officer received 59,323 restricted stock units. Each RSU represents the right to receive one share of Viatris common stock, giving him a potential future equity stake that depends on meeting the time-based vesting schedule disclosed in the filing.

What is the vesting schedule for the 59,323 Viatris (VTRS) RSUs granted to Matthew Maletta?

The RSUs vest in three annual installments. 19,775 units vest on March 6, 2027, and 19,774 units vest on each of March 6, 2028 and March 6, 2029. Vesting is time-based, aligning equity compensation with multi-year service.

Does the Viatris (VTRS) Form 4 show an insider share purchase or sale?

The Form 4 shows an acquisition of restricted stock units as a grant, not an open-market share purchase or sale. The transaction is coded as a grant or award, reflecting standard executive equity compensation rather than trading activity in Viatris stock.

What ownership position is reported after the Viatris (VTRS) RSU grant?

After the grant, the filing reports that Matthew Joseph Maletta directly holds 59,323 restricted stock units. These units represent potential future shares of common stock, subject to the vesting schedule that runs annually from March 2027 through March 2029.
Viatris Inc Ord Shs

NASDAQ:VTRS

View VTRS Stock Overview

VTRS Rankings

VTRS Latest News

VTRS Latest SEC Filings

VTRS Stock Data

15.89B
1.15B
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
CANONSBURG